Patent application number | Description | Published |
20130114009 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE - A liquid crystal medium having an optically isotropic liquid crystal phase is described, which has stability to heat, light and so on, a broad temperature range of liquid crystal phase, a large optical anisotropy and a large dielectric anisotropy. A liquid crystal composition is described, which includes an achiral component T and a chiral dopant and exhibits an optically isotropic liquid crystal phase. The achiral component T contains, as its first component, at least one compound selected from compounds represented by formula (1), | 05-09-2013 |
20130134405 | BENZOFLUORENE COMPOUND, EMISSION MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE - Provided is a benzofluorene compound which exhibits excellent performances when applied to an organic electroluminescent device. | 05-30-2013 |
20130135544 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE - A liquid crystal composition is described, which exhibits an optically isotropic liquid crystal phase and contains an achiral component T and a chiral dopant. The achiral component T contains, as its first component, at least one compound selected from compounds represented by formula (1) in an amount of 32 wt % to 85 wt %, | 05-30-2013 |
20130137850 | NOVEL POLYMER AND PROCESS FOR PRODUCING THE SAME - An objective of the invention is to provide an excellent biomaterial having a good operability and a high safety; the solution is a polymer having one or more peptide units represented by formula (1) as described below and one or more saccharide residues derived from polysaccharides: | 05-30-2013 |
20130144039 | ADSORBENT FOR BLOOD COAGULATION FACTOR OR CELL ADHESION FACTOR AND METHOD FOR PURIFYING THE FACTOR - An objective of the invention is to provide an adsorbent allowing purification of a blood coagulation factor or a cell adhesion factor under mild conditions, according to simple procedures, and at a low cost and safely while having a high affinity and a high resistance to deterioration, and a method for purifying the blood coagulation factor or the cell adhesion factor; a solution is to apply a polypeptide having peptide fragments represented by formula (1) as the adsorbent for the blood coagulation factor or the cell adhesion factor, and to purify the blood coagulation factor or the cell adhesion factor using the adsorbent: | 06-06-2013 |
20130146346 | PHOTOSENSITIVE COMPOSITION FOR TRANSPARENT CONDUCTIVE FILM - A photosensitive composition for forming a photosensitive protective film is described which can provide a transparent conductive film including a nanostructure with a high hardness and environmental resistance. The photosensitive composition contains a compound having a dicyclopentadiene skeleton and an epoxy group or oxetanyl group as a first component, a compound including an (meth)acryl group in a molecule as a second component, an alkali-soluble polymer as a third component, and a solvent as a fourth component. | 06-13-2013 |
20130149743 | METHOD FOR ENHANCING LUMINESCENCE INTENSITY OF CLYTIN-II - A method for enhancing a luminescence activity of clytin-II is provided. A codon-optimized nucleic acid is used for coding the apo-clytin-II protein, and the luminescent activity of the clytin-II is remarkably enhanced when comparing with the conventional use of the wild-type clytin-II. | 06-13-2013 |
20130153829 | COATING FORMING COMPOSITION USED FOR FORMING TRANSPARENT CONDUCTIVE FILM - A subject is to provide a material capable of obtaining a transparent conductive film that is excellent in conductivity, optical transmission, environmental reliability, suitability for process and adhesion in a single application process, and to provide the transparent conductive film and a device element using the same; a solution is to prepare a coating forming composition containing at least one kind selected from the group of metal nanowires and metal nanotubes as a first component, polysaccharides and a derivative thereof as a second component, an active methylene compound as a third component, an electrophilic compound as a fourth component and a solvent as a fifth component to obtain the transparent conductive film by using the coating. | 06-20-2013 |
20130157302 | METHOD FOR DETERMINING CAPABILITY OF A COMPOUND FOR INHIBITING A RECEPTOR USING CODON-OPTIMIZED NUCLEIC ACID - A method for determining a capability of a compound for inhibiting a receptor through a change of intracellular calcium ion when the receptor is activated is provided. Contacting a host cell genetically engineered to express an apo-clytin-II protein generated from a codon-optimized nucleic acid with a test compound, and then determining an amount of light generated. The intracellular calcium ion can be detected much more easily. | 06-20-2013 |
20130203920 | POLYMER COMPOSITION HAVING PHOTOALIGNABLE GROUP, LIQUID CRYSTAL ALIGNMENT FILM FORMED OF THE POLYMER COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE HAVING PHASE DIFFERENCE PLATE FORMED OF THE LIQUID CRYSTAL ALIGNMENT FILM - To provide a photoalignable material that can yield a photoalignable film having a high optical uniformity and no alignment defect, and allows photoalignment with exposure in a short period of time. A photoalignable polymer composition containing a specific photoalignable polymer having a silicone group or a fluorine-substituted alkyl group, and a photoalignable group, and a specific non-photoalignable polymer is manufactured, and the photoalignable film is manufactured by applying the polymer composition onto a base material or the like, drying an applied surface thereon, and irradiating the applied surface with light. | 08-08-2013 |